(BAX) Baxter International Fails to Deliver Swine Flu Vaccine

Baxter International Inc. (BAX) has failed to deliver on its pledge to the U.K. government to supply required quantities of swine flu vaccine, Celvapan. The company has supplied only half of the 400,000 doses of Celvapan it had agreed to supply by the end of Aug 2009.

Britain’s Department of Health allocated Baxter 30 million of the 90 million doses of a $745 million (?450 million) contract placed in May 2009. The remaining 60 million doses were allocated to GlaxoSmithKline plc (GSK).

Baxter has already received contracts from five governments, including the Governments of Ireland and New Zealand, for 80 million doses of swine flu vaccines. The company has decided not to sign any more contracts since it is already running behind schedule.

The U.K. government is working with Baxter to speed up things and improve the supply of vaccines. The government is not seeking any compensation from Baxter right now.

We think that the delay in the delivery of vaccines will damage the reputation of Baxter as a leading contributor to the welfare of society. Most importantly, it will deprive people who are suffering from this pandemic from the right medicine.

Baxter is a leading global medical products and services company that develops, manufactures and markets products to save the lives of millions of people affected by hemophilia, kidney disease, infectious diseases, etc.

Baxter’s main competitors include Becton, Dickinson and Company (BDX) and Johnson & Johnson (JNJ). Baxter’s products are primarily life-sustaining, a hedge against the current economic turmoil

Zacks Investment Research
View original at: Zacks.com News Feed

More on this topic (What's this?)
Added and Updated Valuations – 9/14/09
Return of the Swine Flu: Part 1
Return of the Swine Flu: Part 2
H1N1 Swine Flu Panic
Read more on Baxter International, Influenza outbreak at Wikinvest


Similar Posts: | | | | | | | | | Healthcare | Medical Instruments & Supplies

RSS feeds: BAX | Baxter International | BDX | Becton | Dickinson And Company | Glaxosmithkline plc | GSK | JNJ | Johnson & Johnson | Healthcare | Medical Instruments & Supplies |

Other Posts by vitalstocks | RSS Feed for this author

Post a Response

You must be logged in to post a comment.